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Abstract
Objective Comparing the diagnostic value of multi-sequential
cardiac magnetic resonance imaging (CMR) with
endomyocardial biopsy (EMB) for sub-clinical cardiac allo-
graft rejection.
Methods One hundred and forty-six examinations in 73
patients (mean age 53±12 years, 58 men) were per-
formed using a 1.5 Tesla system and compared to
EMB. Examinations included a STIR (short tau inver-
sion recovery) sequence for calculation of edema ratio
(ER), a T1-weighted spin-echo sequence for assessment
of global relative enhancement (gRE), and inversion-
recovery sequences to visualize late gadolinium en-
hancement (LGE). Histological grade ≥1B was consid-
ered relevant rejection.
Results One hundred and twenty-seven (127/146=87 %)
EMBs demonstrated no or mild signs of rejection
(grades ≤1A) and 19/146 (13 %) a relevant rejection
(grade ≥1B). Sensitivity, specificity, positive predictive, and
negative predictive values were as follows: ER: 63 %, 78 %,
30 %, and 93 %; gRE: 63 %, 70 %, 24 %, and 93 %; LGE:
68 %, 36 %, 13 %, and 87 %; with the combination of ER and
gRE with at least one out of two positive: 84 %, 57 %, 23 %,
and 96 %. ROC analysis revealed an area under the curve of
0.724 for ER and 0.659 for gRE.
Conclusion CMR parameters for myocarditis are useful to
detect sub-clinical acute cellular rejection after heart trans-
plantation. Comparable results to myocarditis can be achieved
with a combination of parameters.
Key Points
• Magnetic resonance imaging is useful for the assessment of
cardiac allograft rejection.
• CMR has a high negative predictive value for exclusion of
allograft rejection.
• Diagnostic performance is not yet good enough to replace
endomyocardial biopsy.
Keywords Heart/transplantation . Graft rejection/diagnosis .
Magnetic resonance imaging . Inflammation .Myocarditis
Abbreviations
ACR Acute cellular rejection
CMR Cardiac magnetic resonance imaging
EMB Endomyocardial biopsy
ER Edema ratio
gRE Global relative enhancement
ISHLT International Society for Heart and Lung
Transplantation
HTx Heart transplantation
LV-EDV Left-ventricular end-diastolic volume
LV-EF Left-ventricular ejection fraction
LV-ESV Left-ventricular end-systolic volume
LGE Late gadolinium enhancement
PPV Positive predictive value
NPV Negative predictive value
STIR Short tau inversion recovery
TE Echo time
TR Repetition time
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Introduction
Endomyocardial biopsy (EMB) is still considered to be the
gold standard for the diagnosis of acute cellular rejection
(ACR) after orthotopic heart transplantation (HTx), despite
many studies also demonstrating promising results for cardiac
magnetic resonance imaging (CMR). However, right ventric-
ular EMB has a number of limitations: (1) it is an inconvenient
invasive procedure with the risk of rare but serious adverse
events like cardiac tamponade or death; (2) substantial expo-
sure to radiation; (3) sampling error; (4) interobserver vari-
ability; (5) wide variability of protocols to use this invasive
interventional tool; (6) repeated EMB may result in cardiac
scarring or venous thrombosis [1, 2]. Therefore, EMB is very
often performed by clinical suspicion of a rejection only, or at
least the frequency of EMB was drastically reduced in many
centres compared to initial protocols. This change of paradigm
is problematic in itself, because clinical non-apparent (sub-
clinical) ACR is not detected [3]. However, repeated sub-
clinical ACRs are known to trigger the development of cardiac
allograft vasculopathy (CAV) [4], a major long-term cause of
graft failure after HTx [5].
A history of acute cellular rejection is an important risk
factor for cardiac allograft vasculopathy (CAV) [6–8], which
is the leading cause of death in heart transplant recipients at
5 years post-transplant, accounting for up to 30% of deaths [5].
CAV develops in a majority of transplanted hearts at a variable
rate, sometimes as early as 3 months after transplantation [9].
In the early post-transplant period, immune mediators like
endothelial damage and inflammatory processes contribute to
intimal thickening of the vascular intima of the cardiac allo-
graft vasculature [10]. Non-immunological factors play a
propagative role in the progression of CAV in the later post-
transplant period [11]. In this context, it is important to iden-
tify patients with inflammatory processes of acute cellular
rejection (ACR) in the cardiac allograft as early as possible.
Although most of these inflammatory processes of ACR are
sub-clinical, these patients need to be monitored more closely
and, additionally, the immunosuppressive therapy needs to be
optimized [12].
In the revision of the ISHLT working formulation for
histological grading of EMB, the classification has been sim-
plified by combining several formerly distinct grades [3].
Grades 1A, 1B, and 2 have been combined into grade 2R.
Yet, many transplant centres are still using the original classi-
fication to distinguish the lower histological grades of ACR in
more detail compared to the revised version. This is supported
by a study by Hollweg et al. [13], showing that grades 1A and
1B are indeed distinct entities with regard to gene expression.
In particular, HTx patients with histological grade 1B showed
an upregulated immune response. The authors concluded that
there are overlapping pathological pathways between grade
1B and grade 3A or 3B of ACR.
On this account, it is an ongoing challenge to find an
accurate and less invasive alternative to EMB for the diagno-
sis of ACR. Multi-sequential CMR has proven its diagnostic
value to detect acute and chronic myocarditis by assessing
myocardial edema, hyperemia, and necrosis [14, 15], which
are also histological findings in ACR [16]. Therefore, CMR
could be useful in this context as well. A couple of previous
studies have compared single CMR parameters with EMB for
the diagnosis of ACR after HTx [17]. Only one study used a
multi-sequential CMR approach like in myocarditis in patients
with moderate to severe ACR and demonstrated a high sensi-
tivity and a moderate specificity [18].
In the present study, we wanted to evaluate the possibility
to detect sub-clinical ACR – which is clinically relevant to
decide if to start medical treatment or not – by a multi-




All patients from our tertiary care centre who were scheduled
for a control EMB after heart transplantation from December
2008 until January 2012 were assessed for their study eligi-
bility. Exclusion criteria included all contraindications for a
contrast-enhanced CMR examination: Presence of cardiac
pacemaker or implantable cardiac defibrillator, other MR in-
compatible devices or implants, claustrophobia, and a history
of severe adverse reactions to gadolinium-based contrast
agents.
Approval was granted by the ethics committee of the
University of Leipzig. Written informed consent was obtained
from all patients. Patient characteristics are summarized in
Table 1.
Endomyocardial biopsies
Right ventricular EMBs were routinely performed six times in
the first year post-transplantation period (day 14 and 1, 3, 6, 9,
and 12 months post HTx) and once per year in the following
years. The classification of the International Society for Heart
and Lung Transplantation (ISHLT) working formulations
1990 was used for histological grading of ACR [3].
Immunosuppressive therapy
All patients received an induction therapy preoperatively with
tacrolimus (1 mg p.o.), mycophenolate mofetil (1,000 mg
p.o.) and corticosteroids (250 mg i.v.). Postoperatively immu-
nosuppressive therapy was continued with tacrolimus (dosing
to target blood concentration), mycophenolate mofetil (2 to
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3 g/d) and corticosteroids (tapering regimen to 2.5 or 5 mg/d)
until side effects occurred. Treatment of biopsy proven acute
rejection in our centre was as follows: Histological grade 1A
was not treated. Grades 1B or higher were treated with a daily
steroid pulse of 500 mg methylprednisone for 3 days, follow-
ed by oral steroid doses of 100 mg daily, tapering down every
3 days by half of the dose until the standard steroid mainte-
nance therapy was reached (5 mg/day). Anti-thymocyte glob-
ulin (1 mg/kg/body weight for 1 to 3 days) was administered
in cases of steroid-resistant ACR or in cases of any cellular
rejection with hemodynamic compromise.
Cardiac magnetic resonance imaging protocol
All 73 patients underwent CMR using a clinical 1.5 T MR
(Philips Achieva, Philips medical systems, Best, the Nether-
lands) and a dedicated cardiac 32-channel phased-array sur-
face coil. The T2-weighted images for the calculation of the
edema ratio (ER) and the T1-weighted spin-echo images to
calculate the global relative enhancement (gRE) were ac-
quired using the body coil to avoid influence of signal hetero-
geneities on signal intensity measurements as previously de-
scribed [14, 15]. This does, however, lead to a decreased
signal-to-noise-ratio (SNR) in comparison to the cardiac sur-
face coil.
For functional analysis, a steady-state free precession se-
quence was performed in the four- and two-chamber view and
in a stack of short-axis slices covering the whole left ventricle.
Acquisition was done during breath hold with retrospective
ECG gating with the following parameters: TR 3.4 ms, TE
1.5 ms, flip angle 60°, slice thickness 8 mm, field of view
320–400 mm, matrix 256x320.
ECG-gated T2-weighted short tau inversion recovery
(STIR) images for ER calculations were acquired in short axis
slices covering the whole left ventricle during end-diastole
while free-breathing using a navigator technique and the same
slice orientation as for the short-axis SSFP-slices with the
following parameters: TR 2 R-R-intervals, TE 80 ms, flip
angle 90°, slice thickness 8 mm, field of view 370x335 mm,
matrix 512x512.
T1-weighted turbo spin-echo imaging was performed
while free breathing starting 15 s after intravenous adminis-
tration of 0.1 mmol/kg body weight of gadobutrol (Gadovist,
Bayer HealthCare Pharmaceuticals, Berlin, Germany). Five
transverse slices covering the left ventricle before and after
contrast administration were acquired with the following pa-
rameters as previously described [6, 7]: TR 1 R-R interval, TE
15ms, flip angle 90°, slice thickness 8 mm, field of view 300–
350 mm, matrix 480x480.
Sequences for the analysis of LGE were acquired at least
10 min after the i.v. administration of contrast agent. A two-
dimensional look-locker sequence was used to determine the
optimal inversion time. Then the left ventricle was covered in
four- and two-chamber orientation with retrospectively ECG-
gated three-dimensional inversion recovery gradient echo se-
quence, TE 6.5 ms, TR 3.1 ms, flip angle 15°, reconstructed
voxel size 1.29 mm, field of view 370 mm, matrix 280x280.
Furthermore, a phase-sensitive inversion recovery (PSIR)
sequence was acquired in short-axis slices covering the whole
ventricle with TE 3.6 ms, TR 1.2 ms, flip angle 15°, FOV
480x382, reconstructed voxel size 1.8 mm, matrix 256x256,
and retrospective ECG gating.
Assessment of left-ventricular size and function
Analysis of left ventricular function was performed in the
short axis cine sequence with commercially available software
(ViewForum R6.3V1L7 or Extended MRWorkspace 2.6.3.4,
Philips medical systems, Best, the Netherlands). End-diastolic
and end-systolic endocardial contours were drawn manually
by an experienced radiologist, with papillary muscles included
in the blood pool. Using the Simpson method, left-ventricular
end-diastolic volume (LV-EDV) and end-systolic volume
(LV-ESV), as well as left-ventricular ejection fraction (LV-
EF), were calculated.
CMR assessment of inflammation
The ER and the gRE were calculated as previously described
[14, 15] from the STIR and T1-weighted TSE sequences.
Table 1 HTx patient characteristics. Abbreviations: ISHLT = International Society of Heart and Lung Transplantation, LV-EF = left-ventricular ejection









Age (years) 52±12 52±12 48±14 0.12
Sex (male/female) 115/31 101/26 14/5 0.55
Months post-transplant 77±21 69±21 77±21 0.13
LV-EF (%) 58±9 58±9 58±10 0.87
LV-EDV (ml) 130±34 131±34 124±28 0.57
LV-ESV (ml) 56±24 56±24 54±22 0.74
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Using commercially available software (ViewForum
R6.3V1L7 or Extended MRWorkspace 2.6.3.4, Philips med-
ical systems, Best, the Netherlands) two spline-based regions
of interest were drawn on the same slice encompassing the
left-ventricular myocardium and the latissimus dorsi or erector
spinae muscle, respectively. This was repeated on three slices
in the basal, midventricular and apical myocardium for calcu-
lation of the ER (Fig. 1). In the same way, regions of interest
were drawn on one slice of the pre-contrast T1-weighted
sequence and copied to the corresponding image acquired
after adminstration of contrast agent (Fig. 2). ER was then
defined as the mean signal intensity of the myocardium
(SImyo) divided by the mean signal intensity of skeletal
muscle (SIskm): ER=SImyo / SIskm. For statistical
analysis, the average ER of three slices was obtained.
From the signal intensities obtained from the T1 se-
quence, gRE of myocardium compared to skeletal mus-
cle was calculated as defined in previous studies [14,
15]. Similar to the ER, the average of gRE was calcu-
lated from three different slices.
Statistics
All results were given as mean and standard deviations (SD).
Q-Q plots and Kolomogorov-Smirnov test were used to ana-
lyse distribution of data. Depending on whether the distribu-
tion was different from normality, the significance of differ-
ences was analysed using Student’s unpaired t-test, Wilcoxon
test or Mann–Whitney rank sum test, where appropriate.
Multiple groups were compared using the Kruskal–Wallis
one-way analysis of variance for all but the patients with a
histological grade 2 and 3A, as the numbers in these sub-
groups were too small (one and two patients, respectively). As
LGE was only recorded as a binary variable (positive or
negative), Fisher's exact test was used for comparison. Two-
tailed P-values <0.05 were considered statistically significant.
For evaluation in a clinical context, patients with a therapeu-
tically relevant rejection (histological grade ≥1B) were com-
pared against a control group including all patients with
grades 0 or 1A. Regarding these two subgroups, sensitivity,
specificity, NPV, and PPV were calculated using ER, gRE,
LGE, and the cutoff values derived from receiver operating
characteristic (ROC) analysis for the ER and gRE values
(Fig. 3).
For the assessment of inter- and intra-observer vari-
ability, ER and gRE were calculated in 20 randomly
selected examinations two times by the same radiologist
and independently by a second radiologist. Analysis was
made as described by Bland and Altman [19]. The
coefficient of variation was calculated as the standard
deviation of the mean difference between measurements,
divided by the mean value for the specific parameter.
All statistics were calculated using commercially avail-
able software (IBM SPSS, Version 19, IBM corporation,
New York, NY, USA).
Results
Patient characteristics
In the period denoted above, 73 patients with cardiac allograft
were scheduled for EMB and CMR on the same day. As some
patients underwent CMR and EMB more than once during
this period, a total of 168 examinations could be acquired.
Twenty-two (22/168) CMR examinations were excluded from
the study, because (1) the EMB material was not sufficient for
histological grading according to the ISHLT guidelines (n=
18/168 [11 %]), or (2) CMR examinations were aborted too
early due to patient discomfort (n=4/168 [2.4 %]). In total,
146 examinations could be included in the study to compare
CMR with EMB findings (Table 1).
Endomyocardial biopsy (EMB)
One hundred and twenty-seven (127/146=87 %) EMBs dem-
onstrated no or mild signs of rejection, histological grade 0
(n=50) and grade 1A (n=77). In 19 examinations (19/146=
13 %) of HTx patients, EMBs revealed relevant ACR
(grade ≥1B) requiring medical anti-inflammatory treat-
ment according to the ISHLT classification from 1990
[3]. Among these, there was one patient with histolog-
ical grade 2 and two patients with grade 3A rejection.
The other 16 samples were classified as histological
grade 1B.
Fig. 1 Short-axis STIR image with ROIs drawn in the myocardium and
skeletal muscle. Edema Ratio (ER) is 3.0
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Cardiac magnetic resonance imaging
Functional and volumetric left-ventricular parameters
The mean LV-EF of all CMR examinations was within the
normal range with 58±9 %, as well as the mean LV-EDVand
LV-ESV with 130±56 ml and 56±24 ml, respectively. There
were no statistically significant differences between the dif-
ferent subgroups, patients with or without clinically relevant
ACR (Table 1). Within the different histological subgroups,
patients with histological grades 0 and 1A had a mean LV-EF
of 58±9 %, a mean LV-EDV of 131±34 ml and LV-ESV
of 56±24 ml. Mean values for patients with histological
grade ≥1B were 58±10 %, 124±28 ml and 54±22 ml.
Receiver operator characteristic (ROC) analysis
The receiver operator characteristic analysis revealed an area
under the curve (AUC) of 0.724 for ER and 0.659 for gRE
(Fig. 3). Detailed analysis confirmed thresholds of 2.0 for ER
and 4.5 for gRE as the most reasonable compromise between
high specificity and sensitivity.
Edema ratio (ER)
Mean and standard deviation of ER indicating edema were
1.8±0.4 for all examinations and 1.7±0.4 for histological
grades 0-1A. Values for patients with a clinically relevant
histological grade ≥1B were only slightly, but significantly
(p<0.05) elevated with a mean value of 2.1±0.5 (Fig. 4a).
For the Kruskal–Wallis test, a significant difference among
the individual histological grades was observed (p=0.03).
Post hoc analysis showed significant differences between the
histological grades 0 and 1B (p=0.002), as well as between
histological grades 1A and 1B, but not between grades 0 and
1A (p=0.38). Regarding the two clinically distinct subgroups,
ER in patients with therapeutically relevant rejection was
significantly higher compared to controls (p=0.002)
(Fig. 4a). Using the standardized cutoff values for myocarditis
[6, 7], the comparison of ER with the histological grade of
rejection as the standard of reference had a sensitivity,
specificity, PPV, and NPV of 63 %, 78 %, 30 %, and
93 % (Table 2).
Global relative myocardial enhancement (gRE)
Mean and standard deviation of gRE were 4.4±1.8 for all
examinations, 4.2±1.7 for histological grades 0/1A, and 5.3±
2.3 (Fig. 4b) for patients with clinically relevant grade ≥1B,
significantly higher than the published threshold of 4.0 [6, 7]
for myocarditis as well as the higher cutoff (4.5) derived from
our ROC analysis.
No significant differences between individual histological
grades were found. However, gRE of patients with clinically
relevant rejection (≥1B) differed significantly from patients
without clinically relevant ACR (≤1A) with p=0.025
(Fig. 4b). For the detection of histological grade ≥1B sensi-
tivity, specificity, PPV, and NPV were 63 %, 70 %, 24 %, and
93 %, respectively (Table 2).
Late gadolinium enhancement (LGE)
LGE of the myocardium could be demonstrated in 101 of 146
MR examinations (69 %). Of these examinations, only 13
(9 %) coincided with a positive (grade ≥1B) result of the
EMB. There was no significant difference in the occurrence
of LGE between patients with or without therapeutically rel-
evant rejection. Regarding the diagnosis of histological
grade ≥1B, a moderate sensitivity of 68 % and NPVof 87 %
was found, whereas specificity and PPV were low with 31 %
and 13 %, respectively (Table 2).
Combination of CMR parameters
Best results regarding sensitivity and NPV were achieved by
combining several of these parameters (Table 2). Defining an
Fig. 2 Transverse T1-weighted
TSE sequence before (a) and after
contrast injection (b) with ROIs
drawn in the myocardium and
skeletal muscle. Global relative
enhancement (gRE) is 3.0
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examination with at least one parameter out of three as posi-
tive, a very high sensitivity of 95 % and a very high NPVof
96 % could be achieved, though specificity was very low with
only 18 %.
Defining either elevated ER and/or gRE as positive
(at least one out of two) resulted in a high sensitivity of
84 %, moderate specificity of 57 % and an equally
good NPV of 96 %.
Both patients with histological grade 3A rejection showed
an elevated ER, gRE as well as LGE. CMR of the patient with
grade 2 rejection was only noticeable for LGE whereas ER
and gRE were within the normal range.
Fig. 3 Receiver operator
characteristic (ROC) analysis for
the CMR parameters ER (a) and
gRE (b) for the diagnosis of
therapeutically relevant rejection
(grade≥1B) as compared to the
results of EMB demonstrate good
results for both parameters with
an area under the curve (AUC) of
0.724 for the ER (a) and 0.659
for the gRE (b)
Eur Radiol (2014) 24:2360–2371 2365
Inter- and intra-observer variability
For the intra-observer variability, mean difference±standard
deviation was 0.09±0.23 for ER and −0.25±1.13 for gRE,
with the coefficient of variation being 12 % and 27 %,
respectively.
In the inter-observer comparison, mean difference±
standard deviation was 0.03±0.25 for ER and −0.85±
2.85 for gRE, with coefficients of variation of 14 % and
38 %.
Analysis of the Bland – Altman plots revealed an increase
in intra- and interobserver differences in patients with higher
gRE values.
Fig. 4 The box-plots of the ER
(a) and gRE (b) in patients with
histological grade 0 and 1A
(n=127) vs. patients with grade
1B or higher (n=19)
demonstrated with statistically
significant differences (*p<0.05)
Table 2 Sensitivity, specificity, and positive (PPV) and negative predic-
tive values (NPV) of different single and combined CMR parameters for
diagnosis of therapeutically relevant acute rejection (grade ≥1B) as prov-
en by EMB. Abbreviations: ER = edema ratio, gRE = global relative
enhancement, LGE = late gadolinium enhancement
Sensitivity Specificity PPV NPV
ER 63 78 30 93
gRE 63 70 24 93
LGE 68 31 13 87
1 out of 3 (ER, gRE, LGE) 95 18 15 96
2 out of 3 (ER, gRE, LGE) 68 67 24 93
1 out of 2 (ER or gRE) 84 57 23 96
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Discussion
In the current study, a multi-sequential CMR protocol was
used to assess cardiac allograft rejection. For therapeutically
relevant rejection of ISHLT grade 1B or greater, a combina-
tion of cardiac ER and gRE achieved a good NPV 96 %.
However, CMR parameters provided only a low PPVof 30 %
at maximum due to a high number of false positives.
Endomyocardial biopsy (EMB) is still considered the gold
standard for the detection and classification of ACR [3].
However, several CMR studies for the evaluation of ACR
have been carried out since the late 1980s (Table 3) demon-
strating promising results.
As early as 1987, a study of Wisenberg et al. [22] explored
the potential of CMR in a small group of 25 patients after
HTx. They found significantly increased T1- and T2-values,
and an increased wall thickness in HTx patients compared to
healthy controls. Using a threshold of two standard deviations
above the mean, cases of rejection could be identified with
high accuracy. From the numbers stated in their publication, a
very high sensitivity of 93 % and specificity of 96 % could be
calculated. However, a sophisticated histological grading sys-
tem had not yet been established, so rejection was simply
defined by the presence of cellular infiltrates and
myocytolysis. This and the less efficient immunosuppressive
therapy at that time – which resulted in a high prevalence
(>50 %) of ACR with 13 out of 25 patients – make it difficult
to compare these results withmore recent CMR studies, which
demonstrated less promising results.
Since then, several attempts have beenmade to increase the
use of CMR in HTx patients, with T2-imaging being the most
widely used technique [17]. Several studies could confirm a
significant increase in absolute T2-values [23–25] or relative
T2-signal [20] intensity in patients with ACR. But initial
studies by Lund and Smart et al. were limited by the very
small number of patients [20, 24] and undefined histological
grading [24].
Two studies by Marie et al. included more patients and a
histological grading according to the ISHLT recommenda-
tions [23, 25], just as the study presented here. While identical
imaging parameters were used, the more recent study included
a larger number of examinations (128 vs. 52). Both studies
found the same sensitivity of 89 % for the detection of ACR
(defined as a histological grade ≥2) with a specificity of 91 %
[23] and 70 % [25], respectively. From our data, a lower
sensitivity of 67 % and similar specificity of 73 % for the
detection of histological grade ≥2 could be calculated. How-
ever, we could include only three patients of this subgroup in
our study.
Studies by Revel [21], Mousseaux [26], and Doornbos
et al. [27] revealed contradictory results demonstrating no
association between T2-imaging and ACR. Among these,
one study reported myocardial signal intensity measurements
only [21] instead of absolute T2-relaxation time calculations
or relative signal intensity measurements [20]. The studies by
Mousseaux et al. [26] and Doornbos et al. [27] featured
systolic image acquisition, which may degrade image quality
[28].
Myocardial enhancement after contrast injection has been
studied less often in the context of ACR. Studies by
Mousseaux et al. [26] and Almenar et al. [29] were able to
show a significant increase of myocardial contrast enhance-
ment in patients with ACR. Comparison with our results is
difficult as both studies used different histological and CMR
criteria. Mousseaux et al. [26] defined myocardial enhance-
ment as the difference between maximum signal intensity
post- and pre-contrast, divided by signal intensity pre-
contrast. Almenar et al. [29] defined relative signal intensity
as the ratio of myocardial signal intensity to skeletal muscle
intensity. Relative myocardial uptake was then calculated as
the difference of post- and pre-contrast relative signal intensi-
ty, divided by post-contrast relative signal intensity. For pa-
tients with ≥1 focus of myocyte necrosis, a significantly
higher relative myocardial uptake was found. Neither study
provided cutoff values or diagnostic sensitivity or specificity
for the diagnosis of ACR.
One possible approach to expand further the usefulness of
CMR was the combination of several different imaging tech-
niques in one examination, which was first introduced by
Wisenberg et al. [22] in 1987 and was then almost abandoned
for over more than ten years until Almenar´s [29] and Taylor´s
[18] studies.
In our study, using a multi-sequential CMR protocol orig-
inally established for the detection of myocarditis [14, 15], a
combination of ER and gRE proved to be valuable to rule out
therapeutically relevant ACR with a sensitivity of 84 % and
NPVof 96 %. Also, significant differences of both parameters
were found between patients with a histological grade of
rejection ≥1B compared to the histological grades of rejection
0 and 1A.
Echocardiographic measurements have shown that ventric-
ular function is compromised in severe cases of rejection [30].
Yet, in our study, parameters of left-ventricular morphology
and systolic function did not show a significant correlation
with histological grades. This observation confirms results
from previous studies [18, 29, 31] in HTx patients, but also
on CMR of myocarditis patients [14, 15]. Neither Almenar
and Taylor et al. nor Usman et al. found significant differences
in ventricular function or volumes between patients with and
without ACR. Thus, it seems that functional parameters are
not sensitive enough to detect either sub-clinical ACR or
myocarditis.
Left ventricular ER and gRE have been successfully im-
plemented as parameters for the evaluation of myocardial
inflammation previously [14, 15]. Our findings of moderate
to good sensitivity and specificity of both CMR parameters
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are inferior to values published for acute myocarditis by
Abdel-Aty et al. [32], but better than the results of Gutberlet
et al. [15] for chronic myocarditis.
Thus, though the pathophysiological mechanisms underly-
ing allograft rejection are different from those in acute myo-
carditis, it seems that the common findings of myocardial
edema and hyperaemia lead to similar changes in CMR
parameters.
It must be noted that most studies on CMR in myocarditis
used a gRE cutoff value of 4.0 [14, 15, 32], while Taylor et al.
found a cutoff value of 3.5 for the detection of ACR. Both are
different from the optimal value of 4.5, which was found in
our study via ROC analysis (Fig. 3). Because of the depen-
dence on technical parameters such as field strength and
vendor [33], it may be that this optimum cutoff value found
in our study does not apply to different CMR systems and
sequences.
A combination of the two parameters ER and gRE deliv-
ered the best diagnostic performance with an NPVof 96%. To
date, only one other study [18] has reported on the adoption of
a similar multi-sequential CMR protocol for the evaluation of
ACR.
In a smaller patient population (n=50), using the same
combined criteria approach of either elevated ER or gRE, a
sensitivity of 100 % and specificity of 73 % were achieved for
ACR and the revised ISHLT grading of rejection for grades
2R and higher.
In our patient population, sensitivity, specificity, PPV and
NPV for histological grades 2 and higher were 67 %, 73 %,
5%, 99% for ER; 67%, 66%, 4%, 99% for gRE; and 100%,
31 %, 3 %, 100 % for LGE. This was due to one patient with
histological grade 2 showing normal values for ER and gRE.
Yet, as only three patients with histological grade ≥2 were
included, the significance of these findings could not be
proven from our data.
Different from Taylor et al., the focus of the current study
was to assess low histological grades of rejection without
acute cardiac function compromise but with the risk to trigger
CAV in the long-term. Thus, the original version of the histo-
logical grading of EMB was used, and, indeed, significant
differences for both CMR parameters ER and gRE for patients
with histological grades of rejection ≥1B were found.
This underlines the potential of CMR as a screening tool
for early sub-clinical ACR also.
The diagnostic value of gRE may be diminished by the
high inter- and intra-observer variability found in our study.
This could be due to a different choice of slice to be evaluated
or different selection of the reference muscle. On the other
hand, cardiac T2-imaging as used for the measurement of ER
has also been challenged by technical and pathophysiological
considerations as well as a lack of scientific validation [34].
The currently used sequences may suffer from slow flow
artefacts in the vicinity of hypokinetic myocardium.
Additionally, the contrast-to-noise ratio for the detection of
edema is typically quite low [35].
A promising method to improve diagnostic accuracy and
decrease the variability is the use of quantitative T1- or T2-
mapping, which has shown low variability in small studies
[36, 37]. First, results of a study with 53 HTx patients showed
a significant elevation of myocardial T2-values in patients
with rejection [31]. Yet only four patients were included due
to biologically proven acute rejection (histological grade of
2R or higher), whereas four other patients had assumed he-
modynamic or humoral rejection. Further studies with a larger
number of patients are needed to clarify the value of T2-
mapping alone and in combination with other established
parameters such as gRE or LGE.
The presence of LGE did not correlate with histological
grade in our findings. Nor did the addition of LGE improve
diagnostic performance. These findings are consistent with
previously published results [18], and may be explained by
the small size of areas of myocardial necrosis in ACR.
Additionally, myocardial fibrosis may also occur due to
other causes different from ACR such as perioperative ische-
mia or repeated EMB [2]. An analysis of the specific pattern of
LGE may increase its usefulness and has been shown to
correlate with the presence of transplant coronary artery vas-
culopathy [38], which was not in the focus of our present
study. Furthermore, the myocardial fibrosis in ACR might be
diffuse and might be therefore not detectable by simple “eye-
balling” like in this study.
Though our data pool is larger than in most other studies
with 146 examinations from 73 patients, it is limited by the
small number of positive EMB results. Because of the highly
efficacious immunosuppressive therapy, biopsy-proven acute
rejection of histological grades 2 and higher was rare among
the included patients. A larger, multi-centre trial may be
necessary to acquire a database with a larger number of cases.
Our study aimed to detect low grade ACR, which is sub-
clinical in most cases [12]. In accordance with this, we did not
find any significant difference in cardiac function parameters
between patients with and without ACR. However, clinical
information was not assessed for the current study, so it cannot
be ruled out that a certain number of patients in our group with
therapeutically relevant rejection exhibited clinical symptoms.
This issue could be addressed in future studies by dedicated
analysis of patient groups with our without clinical signs of
rejection.
A different approach for the detection of ACR is the
measurement of biomarkers derived from blood samples.
Studies have shown promising results for the use of high
sensitivity troponin assays [39, 40], brain natriuretic peptide
[41], or genomic profiling [13, 42]. These methods could
provide an even simpler and more readily available tool to
monitor patients after HTx. However, other than CMR, they
do not provide additional morphological or functional
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information. More data are needed to assess the potential of
biomarkers alone or in combination with imaging techniques
such as CMR.
In conclusion, our study demonstrated that a multi-
sequential CMR examination has the potential of a non-
invasive tool for exclusion of sub-clinical ACR in HTx pa-
tients with comparable results to CMR inmyocarditis patients.
Yet, the diagnostic performance on the whole is limited by
rather poor specificity and, therefore, limited PPV. A decision
to change the immunosuppressive therapy, therefore, cannot
be made based on CMR results alone, but in combination with
clinical information. Thus, CMR might be used instead of
surveillance EMB, with positive CMR results leading to fur-
ther clarification by clinical or laboratory findings and EMB.
Secondly, CMR could be employed to monitor patients with
low grade ACR over time.
Larger studies incorporating new techniques such as T1-
and T2- mapping may hold the promise to overcome the
present limitations and further establish CMR for the routine
diagnostic workup of HTx patients until a completely non-
invasive diagnostic management of patients after HTx may
become possible.
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